The clinical efficacy of adefovir dipivoxil combined with reduced glutathione therapy for decompensated hepatitis B cirrhosis / 重庆医学
Chongqing Medicine
; (36): 1093-1094,1097, 2014.
Article
de Zh
| WPRIM
| ID: wpr-553876
Bibliothèque responsable:
WPRO
ABSTRACT
Objective To study the clinical efficay of the therapy adefovir dipivoxil combined with reduced glutathione in the treatment of decompensated hepatitis B cirrhosis .Methods 76 cases of decompensated hepatitis B cirrhosis were divided into the treatment group and the control group ,38 cases in each group .Both groups take symptomatic and supportive treatment ,the obser-vation group plus adefovir dipivoxil combined with glutathione therapy .After 3 months treatment ,we observed liver function ,hepa-titis B virus DNA quantification and assessed the clinical efficacy .Results After treatment ,the treatment group liver function im-proved was significantly better than the control group (P<0 .05) ,the total effective rate was higher than the control group (P<0 .05) ,the rate of hepatitis B virus DNA turn to negative was significantly higher than the control group (P<0 .01) .Conclusion Adefovir dipivoxil combined with reduced glutathione therapy for decompensated hepatitis B cirrhosis can effectively improve liver function ,suppress hepatitis B virus DNA undetectable ,reduce the incidence of the complication ,and worthy of promote in our clini-cal practice .
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chongqing Medicine
Année:
2014
Type:
Article